ALSO NOTED: Bayer ups Schering bid; Antibiotic may work against serious asthma attack; and much more...

> Bayer slightly upped its official bid for Germany's Schering, offering $20.01 billion. Schering's board has recommended the offer. Report [1]

> Researchers say the antibiotic telithromycin, usually used to treat sinusitis, may also help people deal with serious asthma attacks. Report [2]

> Pharmacopeia Drug Discovery will gain a milestone on Schering-Plough's decision to develop one of its compounds for respiratory illness. Report [3]

> Fisher Scientific International is buying Clintrak Pharmaceutical Services for $125 million. Clintrak provides clinical trial printing services. Report [4]

> Edinburgh-based Ardana says that its cream for testosterone deficiency passed a mid-stage trial with 42 patients. Article [5]

> Novacea has launched a Phase III trial for its cancer therapy DN-101. Release [6]

> Chutes & Ladders: ArQule CFO Louise Mahoney is leaving, but plans to stay on until her successor has been named. Report [7]

And Finally… A British court ruling may clear the way for hundreds of women to obtain the breast-cancer therapy Herceptin. Article [8]